Synopsis
0
CEP/COS
0
VMF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
Market Place
ABOUT THIS PAGE
99
PharmaCompass offers a list of Cilnidipine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Cilnidipine manufacturer or Cilnidipine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Cilnidipine manufacturer or Cilnidipine supplier.
PharmaCompass also assists you with knowing the Cilnidipine API Price utilized in the formulation of products. Cilnidipine API Price is not always fixed or binding as the Cilnidipine Price is obtained through a variety of data sources. The Cilnidipine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Cilnidipine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Cilnidipine, including repackagers and relabelers. The FDA regulates Cilnidipine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Cilnidipine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Cilnidipine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Cilnidipine supplier is an individual or a company that provides Cilnidipine active pharmaceutical ingredient (API) or Cilnidipine finished formulations upon request. The Cilnidipine suppliers may include Cilnidipine API manufacturers, exporters, distributors and traders.
click here to find a list of Cilnidipine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Cilnidipine DMF (Drug Master File) is a document detailing the whole manufacturing process of Cilnidipine active pharmaceutical ingredient (API) in detail. Different forms of Cilnidipine DMFs exist exist since differing nations have different regulations, such as Cilnidipine USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Cilnidipine DMF submitted to regulatory agencies in the US is known as a USDMF. Cilnidipine USDMF includes data on Cilnidipine's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Cilnidipine USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Cilnidipine suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Cilnidipine Drug Master File in Japan (Cilnidipine JDMF) empowers Cilnidipine API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Cilnidipine JDMF during the approval evaluation for pharmaceutical products. At the time of Cilnidipine JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Cilnidipine suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Cilnidipine Drug Master File in Korea (Cilnidipine KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Cilnidipine. The MFDS reviews the Cilnidipine KDMF as part of the drug registration process and uses the information provided in the Cilnidipine KDMF to evaluate the safety and efficacy of the drug.
After submitting a Cilnidipine KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Cilnidipine API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Cilnidipine suppliers with KDMF on PharmaCompass.
A Cilnidipine written confirmation (Cilnidipine WC) is an official document issued by a regulatory agency to a Cilnidipine manufacturer, verifying that the manufacturing facility of a Cilnidipine active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Cilnidipine APIs or Cilnidipine finished pharmaceutical products to another nation, regulatory agencies frequently require a Cilnidipine WC (written confirmation) as part of the regulatory process.
click here to find a list of Cilnidipine suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Cilnidipine as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Cilnidipine API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Cilnidipine as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Cilnidipine and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Cilnidipine NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Cilnidipine suppliers with NDC on PharmaCompass.
Cilnidipine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Cilnidipine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Cilnidipine GMP manufacturer or Cilnidipine GMP API supplier for your needs.
A Cilnidipine CoA (Certificate of Analysis) is a formal document that attests to Cilnidipine's compliance with Cilnidipine specifications and serves as a tool for batch-level quality control.
Cilnidipine CoA mostly includes findings from lab analyses of a specific batch. For each Cilnidipine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Cilnidipine may be tested according to a variety of international standards, such as European Pharmacopoeia (Cilnidipine EP), Cilnidipine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Cilnidipine USP).
